A methodological and functional proteomic approach of human follicular fluid en route for oocyte quality evaluation

Journal of Proteomics

Volumn 90, Issue , 2013, Pages 61-76

  Bianchi, L ^a   Gagliardi, A ^a   Campanella, G ^b   Landi, C ^a   Capaldo, A ^a   Carleo, A ^a   Armini, A ^a   De Leo, V ^c   Piomboni, P ^a   Focarelli, R ^a   Bini, L ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Functional proteomics; Human follicular fluid; In vitro fertilization; Inflammatory reaction; Oocyte quality; Ovulation

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; KALLIKREIN; BIOLOGICAL MARKER; PROTEOME;

ADULT; AMINO ACID SEQUENCE; ARTICLE; ARTIFACT; BLOOD CLOTTING; CLINICAL ARTICLE; CROSS LINKING; DEGRADATION; EXTRACELLULAR MATRIX; FEMALE; FERTILIZATION IN VITRO; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN TISSUE; INCIDENCE; INFERTILITY; INFLAMMATION; MASS SPECTROMETRY; METHODOLOGY; OOCYTE; OVARY FOLLICLE FLUID; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; SERUM; SIGNAL TRANSDUCTION; SOLUBILIZATION; WESTERN BLOTTING; CHEMISTRY; CLINICAL TRIAL; METABOLISM; PROCEDURES; PROTEOMICS;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLICULAR FLUID; HUMANS; PROTEOME; PROTEOMICS;

EID: 84882641362     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.02.025     Document Type: Article

References (107)

1. Gosden R.G., Hunter R.H., Telfer E., Torrance C., Brown N. Physiological factors underlying the formation of ovarian follicular fluid. J Reprod Fertil 1988, 82(2):813-825.
2. Rodgers R.J., Irving-Rodgers H.F. Formation of the ovarian follicular antrum and follicular fluid. Biol Reprod 2010, 82(6):1021-1029.
3. Kolialexi A., Mavrou A., Spyrou G., Tsangaris G.T. Mass spectrometry-based proteomics in reproductive medicine. Mass Spectrom Rev 2008, 27(6):624-634.
4. Schweigert F.J., Gericke B., Wolfram W., Kaisers U., Dudenhausen J.W. Peptide and protein profiles in serum and follicular fluid of women undergoing IVF. Hum Reprod 2006, 21(11):2960-2968.
5. Gérard N., Loiseau S., Duchamp G., Seguin F. Analysis of the variations of follicular fluid composition during follicular growth and maturation in the mare using proton nuclear magnetic resonance (1H NMR). Reproduction 2002, 124(2):241-248.
6. Kim Y.S., Kim M.S., Lee S.H., Choi B.C., Lim J.M., Cha K.Y., et al. Proteomic analysis of recurrent spontaneous abortion: identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics 2006, 6(11):3445-3454.
7. Von Wald T., Monisova Y., Hacker M.R., Yoo S.W., Penzias A.S., Reindollar R.R., et al. Age-related variations in follicular apolipoproteins may influence human oocyte maturation and fertility potential. Fertil Steril 2010, 93(7):2354-2361.
8. Revelli A., Delle Piane L., Casano S., Molinari E., Massobrio M., Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009, 7:40.
9. Balaban B., Urman B. Effect of oocyte morphology on embryo development and implantation. Reprod Biomed Online 2006, 12(5):608-615.
10. Ebner T., Moser M., Sommergruber M., Tews G. Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum Reprod Update 2003, 9(3):251-262.
11. Ebner T., Moser M., Tews G. Is oocyte morphology prognostic of embryo developmental potential after ICSI?. Reprod Biomed Online 2006, 12(4):507-512.
12. Rienzi L., Ubaldi F.M., Iacobelli M., Minasi M.G., Romano S., Ferrero S., et al. Significance of metaphase II human oocyte morphology on ICSI outcome. Fertil Steril 2008, 90(5):1692-1700.
13. Borini A., Lagalla C., Cattoli M., Sereni E., Sciajno R., Flamigni C., et al. Predictive factors for embryo implantation potential. Reprod Biomed Online 2005, 10(5):653-668.
14. Racowsky C., Vernon M., Mayer J., Ball G.D., Behr B., Pomeroy K.O., et al. Standardization of grading embryo morphology. Fertil Steril 2010, 94(3):1152-1153.
15. Guerif F., Le Gouge A., Giraudeau B., Poindron J., Bidault R., Gasnier O., et al. Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: a prospective study based on 4042 embryos. Hum Reprod 2007, 22(7):1973-1981.
16. Twigt J., Steegers-Theunissen R.P., Bezstarosti K., Demmers J.A. Proteomic analysis of the microenvironment of developing oocytes. Proteomics 2012, 12(9):1463-1471.
17. Kushnir M.M., Naessén T., Wanggren K., Rockwood A.L., Crockett D.K., Bergquist J. Protein and steroid profiles in follicular fluid after ovarian hyperstimulation as potential biomarkers of IVF outcome. J Proteome Res 2012, 11(10):5090-5100.
18. Jarkovska K., Kupcova Skalnikova H., Halada P., Hrabakova R., Moos J., Rezabek K., et al. Development of ovarian hyperstimulation syndrome: interrogation of key proteins and biological processes in human follicular fluid of women undergoing in vitro fertilization. Mol Hum Reprod 2011, 17(11):679-692.
19. Yoo S.W., Savchev S., Sergott L., Rezai T., Lopez M.F., Von Wald T., et al. A large network of interconnected signaling pathways in human ovarian follicles is supported by the gene expression activity of the granulosa cells. Reprod Sci 2011, 18(5):476-484.
20. Jarkovska K., Martinkova J., Liskova L., Halada P., Moos J., Rezabek K., et al. Proteome mining of human follicular fluid reveals a crucial role of complement cascade and key biological pathways in women undergoing in vitro fertilization. J Proteome Res 2010, 9(3):1289-1301.
21. Hanrieder J., Zuberovic A., Bergquist J. Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling-exemplified on human follicular fluid. J Chromatogr A 2009, 1216(17):3621-3628.
22. Liu A.X., Zhu Y.M., Luo Q., Wu Y.T., Gao H.J., Zhu X.M., et al. Specific peptide patterns of follicular fluids at different growth stages analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biochim Biophys Acta 2007, 1770(1):29-38.
23. Hanrieder J., Nyakas A., Naessén T., Bergquist J. Proteomic analysis of human follicular fluid using an alternative bottom-up approach. J Proteome Res 2008, 7(1):443-449.
24. Angelucci S., Ciavardelli D., Di Giuseppe F., Eleuterio E., Sulpizio M., Tiboni G.M., et al. Proteome analysis of human follicular fluid. Biochim Biophys Acta 2006, 1764(11):1775-1785.
25. Lee H.C., Lee S.W., Lee K.W., Lee S.W., Cha K.Y., Kim K.H., et al. Identification of new proteins in follicular fluid from mature human follicles by direct sample rehydration method of two-dimensional polyacrylamide gel electrophoresis. J Korean Med Sci 2005, 20(3):456-460.
26. Maniwa J., Izumi S., Isobe N., Terada T. Studies on substantially increased proteins in follicular fluid of bovine ovarian follicular cysts using 2-D PAGE and MALDI-TOF MS. Reprod Biol Endocrinol 2005, 3:23.
27. Anahory T., Dechaud H., Bennes R., Marin P., Lamb N.J., Laoudj D. Identification of new proteins in follicular fluid of mature human follicles. Electrophoresis 2002, 23(7-8):1197-1202.
28. Spitzer D., Murach K.F., Lottspeich F., Staudach A., Illmensee K. Different protein patterns derived from follicular fluid of mature and immature human follicles. Hum Reprod 1996, 11(4):798-807.
29. Weiss W., Görg A. High-resolution two-dimensional electrophoresis. Methods Mol Biol 2009, 564:13-32.
30. Görg A., Weiss W., Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 12:3665-3685.
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
32. Bjellqvist B., Pasquali C., Ravier F., Sanchez J.C., Hochstrasser D. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis 1993, 14(12):1357-1365.
33. Görg A., Postel W., Günther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988, 9(9):531-546.
34. Hochstrasser D., Patchornik A., Merril C.R. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988, 173(2):412-423.
35. Oakley B.R., Kirsch D.R., Morris N.R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980, 105(2):361-363.
36. Sinha P., Poland J., Schnolzer M., Rabilloud T. A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis. Proteomics 2001, 1(7):835-840.
37. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
38. Gimigliano A., Mannini L., Bianchi L., Puglia M., Deardorff M.A., Menga S., et al. Proteomic profile identifies dysregulated pathways in Cornelia de Lange syndrome sells with distinct mutations in SMC1A and SMC3 genes. J Proteome Res 2012, 11(12):6111-6123.
39. Bianchi L., Gagliardi A., Gioia R., Besio R., Tani C., Landi C., et al. Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach. J Proteomics 2012, 5(15):4717-4733.
40. Bianchi L., Bruzzese F., Leone A., Gagliardi A., Puglia M., Di Gennaro E., et al. Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells. Proteomics 2011, 11:3725-3742.
41. Marotta L.L., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., et al. The JAK2/STAT3 signaling pathway is required for growth of CD44CD24 stem cell-like breast cancer cells in human tumors. J Clin Invest 2011, 121:2723-2735.
42. Nikolsky Y., Kirillov E., Zuev R., Rakhmatulin E., Nikolskaya T. Functional analysis of OMICs data and small molecule compounds in an integrated "knowledge-based" platform. Methods Mol Biol 2009, 563:177-196.
43. Nambiar P.R., Gupta R.R., Misra V. An "Omics" based survey of human colon cancer. Mutat Res 2010, 693:3-18.
44. Vellaichamy A., Dezso Z., JeBailey L., Chinnaiyan A.M., Sreekumar A., Nesvizhskii A.I., et al. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response. PLoS One 2010, 5:e10936.
45. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979, 76:4350-4354.
46. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
47. Winkler W., Zellner M., Diestinger M., Babeluk R., Marchetti M., Goll A., et al. Biological variation of the platelet proteome in the elderly population and its implication for biomarker research. Mol Cell Proteomics 2008, 7(1):193-203.
48. Hughes G.J., Frutiger S., Paquet N., Ravier F., Pasquali C., Sanchez J.C., et al. Plasma protein map: an update by microsequencing. Electrophoresis 1992, 13(9-10):707-714.
49. Lescuyer P., Hochstrasser D., Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery?. J Proteome Res 2007, 6(9):3371-3376.
50. Otsuki J., Nagai Y., Matsuyama Y., Terada T., Era S. The influence of the redox state of follicular fluid albumin on the viability of aspirated human oocytes. Syst Biol Reprod Med 2012, 58(3):149-153.
51. Espey L.L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994, 50(2):233-238.
52. Spanel-Borowski K. Ovulation as danger signaling event of innate immunity. Mol Cell Endocrinol 2011, 333(1):1-7.
53. Jabbour H.N., Sales K.J., Catalano R.D., Norman J.E. Inflammatory pathways in female reproductive health and disease. Reproduction 2009, 138(6):903-919.
54. Oktem O., Oktay K. The ovary: anatomy and function throughout human life. Ann N Y Acad Sci 2008, 1127:1-9.
55. Orvieto R. Controlled ovarian hyperstimulation-an inflammatory state. J Soc Gynecol Investig 2004, 11(7):424-426.
56. Orvieto R., Chen R., Ashkenazi J., Ben-Haroush A., Bar J., Fisch B. C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle. Hum Reprod 2004, 19(2):357-359.
57. Murdoch W.J., Murphy C.J., Van Kirk E.A., Shen Y. Mechanisms and pathobiology of ovulation. Soc Reprod Fertil Suppl 2010, 67:189-201.
58. Rodgers R.J., Irving-Rodgers H.F. The roles of the ovarian extracellular matrix in fertility. Soc Reprod Fertil Suppl 2010, 67:217-230.
59. Irving-Rodgers H.F., Rodgers R.J. Extracellular matrix of the developing ovarian follicle. Semin Reprod Med 2006, 24(4):195-203.
60. Berkholtz C.B., Shea L.D., Woodruff T.K. Extracellular matrix functions in follicle maturation. Semin Reprod Med 2006, 24(4):262-269.
61. Russell D.L., Salustri A. Extracellular matrix of the cumulus-oocyte complex. Semin Reprod Med 2006, 24(4):217-227.
62. Goldman S., Shalev E. MMPS and TIMPS in ovarian physiology and pathophysiology. Front Biosci 2004, 9:2474-2483.
63. Ohnishi J., Ohnishi E., Shibuya H., Takahashi T. Functions for proteinases in the ovulatory process. Biochim Biophys Acta 2005, 1751(1):95-109.
64. Honda T., Fujiwara H., Yoshioka S., Yamada S., Nakayama T., Egawa M., et al. Laminin and fibronectin concentrations of the follicular fluid correlate with granulosa cell luteinization and oocyte quality. Reprod Med Biol 2004, 3:43-49.
65. Iwahashi M., Muragaki Y., Ooshima A., Nakano R. Type VI collagen expression during growth of human ovarian follicles. Fertil Steril 2000, 74(2):343-347.
66. Eriksen G.V., Malmström A., Uldbjerg N. Human follicular fluid proteoglycans in relation to in vitro fertilization. Fertil Steril 1997, 68(5):791-798.
67. Korkmaz B., Moreau T., Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 2008, 90(2):227-242.
68. Heutinck K.M., ten Berge I.J., Hack C.E., Hamann J., Rowshani A.T. Serine proteases of the human immune system in health and disease. Mol Immunol 2010, 47(11-12):1943-1955.
69. Brännström M., Enskog A. Leukocyte networks and ovulation. J Reprod Immunol 2002, 57(1-2):47-60.
70. Liu Y.X. Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Front Biosci 2004, 9:3356-3373.
71. Colgin D.C., Murdoch W.J. Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator. Anim Reprod Sci 1997, 47(3):197-204.
72. Tsafriri A., Bicsak T.A., Cajander S.B., Ny T., Hsueh A.J. Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin. Endocrinology 1989, 124(1):415-421.
73. Cao M., Buratini J., Lussier J.G., Carrière P.D., Price C.A. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle. Reproduction 2006, 131(1):125-137.
74. Murdoch W.J. Proteolytic and cellular death mechanisms in ovulatory ovarian rupture. Biol Signals Recept 2000, 9(2):102-114.
75. Coussens L.M., Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996, 3(11):895-904.
76. Yamamichi S., Fujiwara Y., Kikuchi T., Nishitani M., Matsushita Y., Hasumi K. Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo. Biochem Biophys Res Commun 2011, 409(3):483-488.
77. Horowitz J.C., Rogers D.S., Simon R.H., Sisson T.H., Thannickal V.J. Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol 2008, 38(1):78-87.
78. Rossignol P., Ho-Tin-Noé B., Vranckx R., Bouton M.C., Meilhac O., Lijnen H.R., et al. Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J Biol Chem 2004, 279(11):10346-10356.
79. Doeuvre L., Plawinski L., Goux D., Vivien D., Anglés-Cano E. Plasmin on adherent cells: from microvesiculation to apoptosis. Biochem J 2010, 432(2):365-373.
80. Mao S.S., Cooper C.M., Wood T., Shafer J.A., Gardell S.J. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans. J Biol Chem 1999, 274(49):35046-35052.
81. Römisch J., Vermöhlen S., Feussner A., Stöhr H. The FVII activating protease cleaves single-chain plasminogen activators. Haemostasis 1999, 29(5):292-299.
82. Choi-Miura N.H., Yoda M., Saito K., Takahashi K., Tomita M. Identification of the substrates for plasma hyaluronan binding protein. Biol Pharm Bull 2001, 24:140-143.
83. Dugina T.N., Kiseleva E.V., Chistov I.V., Umarova B.A., Strukova S.M. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Mosc) 2002, 67(1):65-74.
84. Hirota Y., Osuga Y., Yoshino O., Koga K., Yano T., Hirata T., et al. Possible roles of thrombin-induced activation of protease-activated receptor 1 in human luteinized granulosa cells. J Clin Endocrinol Metab 2003, 88(8):3952-3957.
85. Roach L.E., Petrik J.J., Plante L., LaMarre J., Gentry P.A. Thrombin generation and presence of thrombin receptor in ovarian follicles. Biol Reprod 2002, 66(5):1350-1358.
86. Ebner T., Moser M., Shebl O., Sommergruber M., Yaman C., Tews G. Blood clots in the cumulus-oocyte complex predict poor oocyte quality and post-fertilization development. Reprod Biomed Online 2008, 16(6):801-807.
87. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57(1):27-77.
88. Hillmeister P., Persson P.B. The kallikrein-kinin system. Acta Physiol (Oxf) 2012, 206(4):215-219.
89. Plendl J., Snyman C., Bhoola K.D. Expression of the tissue kallikrein-kinin cascade in granulosa cells of the ovary. Biol Chem 2002, 383(12):1917-1924.
90. Plendl J., Snyman C., Bhoola K.D. Visualization of the sequential changes in immunolabelled tissue kininogenase which accompany follicular development and luteinization of angiogenic granulosa cells of the ovary. Int Immunopharmacol 2002, 2(13-14):1981-1994.
91. Ilha G.F., dos Santos J.T., da Silveira A.M., Gutierrez K., Gewehr Cde C., de Oliveira S.M., et al. Characterization of the kallikrein-kinin system during the bovine ovulation process. Peptides 2011, 32(10):2122-2126.
92. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007 Mar, 8(3):221-233.
93. Peluffo M.C., Murphy M.J., Baughman S.T., Stouffer R.L., Hennebold J.D. Systematic analysis of protease gene expression in the rhesus macaque ovulatory follicle: metalloproteinase involvement in follicle rupture. Endocrinology 2011, 152(10):3963-3974.
94. Siefert S.A., Sarkar R. Matrix metalloproteinases in vascular physiology and disease. Vascular 2012, 20(4):210-216.
95. Liu K., Olofsson J.I., Wahlberg P., Ny T. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum. Endocrinology 1999, 140(11):5330-5338.
96. Anacker J., Segerer S.E., Hagemann C., Feix S., Kapp M., Bausch R., et al. Human decidua and invasive trophoblasts are rich sources of nearly all human matrix metalloproteinases. Mol Hum Reprod 2011, 17(10):637-652.
97. Newby A.C. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol 2012, 56(5-6):232-244.
98. Cauwe B., Opdenakker G. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. Crit Rev Biochem Mol Biol 2010, 45(5):351-423.
99. Rosewell K., Al-Alem L., Li F., Kelty B., Curry T.E. Identification of hepsin and protein disulfide isomerase A3 as targets of gelatinolytic action in rat ovarian granulosa cells during the periovulatory period. Biol Reprod 2011, 85(4):858-866.
100. Baka S., Zourla K., Kouskouni E., Makrakis E., Demeridou S., Tzanakaki D., et al. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation. In Vivo 2010, 24(3):293-296.
101. Horka P., Malickova K., Jarosova R., Janatkova I., Zima T., Kalousova M. Matrix metalloproteinases in serum and the follicular fluid of women treated by in vitro fertilization. J Assist Reprod Genet 2012, 29(11):1207-1212.
102. Stilley J.A., Birt J.A., Nagel S.C., Sutovsky M., Sutovsky P., Sharpe-Timms K.L. Neutralizing TIMP1 restores fecundity in a rat model of endometriosis and treating control rats with TIMP1 causes anomalies in ovarian function and embryo development. Biol Reprod 2010, 83(2):185-194.
103. Stilley J.A., Sharpe-Timms K.L. TIMP1 contributes to ovarian anomalies in both an MMP-dependent and -independent manner in a rat model. Biol Reprod 2012, 86(2):47. [Print 2012 Feb.].
104. Imoedemhe D., Shaw R.W. Follicular fluid alpha 1-antitrypsin-correlation with fertilizing capacity of oocytes. Br J Obstet Gynaecol 1986, 93(8):863-868.
105. Nagy B., Pulay T., Szarka G., Csömör S. The serum protein content of human follicular fluid and its correlation with the maturity of oocytes. Acta Physiol Hung 1989, 73(1):71-75.
106. Zhou A., Carrell R.W. Dimers initiate and propagate serine protease inhibitor polymerisation. J Mol Biol 2008, 375(1):36-42.
107. Janciauskiene S.M., Bals R., Koczulla R., Vogelmeier C., Köhnlein T., Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011, 105(8):1129-1139.